Background. Molecular profile of glioblastoma multiforme (GBM) revealed 4 subtypes, 2 of which, proneural and mesenchymal, have been predominantly observed, with the latter displaying a more aggressive phenotype and increased therapeutic resistance. Single-cell RNA sequencing revealed that multiple subtypes actually reside within the same tumor, suggesting cellular heterogeneity in GBM. Further, plasticity between these 2 subtypes is observed during tumor recurrence and in response to radiation therapy. Methods. Patient-derived GBM stemlike cells were cultured as neurospheres. These cells were differentiated in serum by attaching to the culture dishes. The "floating" cells that were not attached/differentiated were harvested from the conditioned medium. The characteristics of these cells were studied with limiting dilution assays and immunofluorescence staining. Cell growth and nuclear factor-kappaB (NFkB) activation were monitored using bioluminescent assays as well as quantitative polymerase chain reaction and western blotting. In vivo tumorigenesis was evaluated in orthotopic xenograft models using bioluminescence imaging. Results. Patient-derived GBM stemlike cells undergo differentiation by attaching to the culture dish in serumcontaining medium. We observed that a small subset of these cells escape this adhesion/differentiation and grow as floating cells. These cells displayed enhanced cancer stem cell properties with a molecular and phenotypic mesenchymal signature, including resistance to radiation and targeted therapies, a more aggressive tumor formation, and NFkB activation. Conclusion. Our results endorse inherent intratumor molecular subtype heterogeneity in glioblastoma and provide a valuable approach to study phenotypic plasticity, which could be applied to find novel therapeutic strategies to eradicate this aggressive tumor and can be extended to other cancer types.
Materials and Methods

Cell Culture, Constructions and Reagents
Primary GSCs used in this study were derived from surgical specimens obtained from glioblastoma patients undergoing treatment at the Massachusetts General Hospital or The Ohio State University James Comprehensive Cancer Center, in accordance with the appropriate institutional review board approval, and have been previously characterized. 9, 18, 19 GSCs are cultured as neurospheres in serum-free neurobasal medium supplemented with human recombinant epidermal growth factor and basic fibroblast growth factor (NBM). For bioluminescence imaging, cells were transduced with the CSCW-Fluc-IRESmCherry lentivirus vector carrying an expression cassette for firefly luciferase (Fluc) and mCherry fluorescent protein. 20 Temozolomide was purchased from Sigma Aldrich. Detailed methods for different experiments can be found in the Supplementary material.
Immunocytochemistry
Cells were plated on Nunc Lab-tek II chamber slides (Sigma-Aldrich), in the presence of Synthemax II-SC substrate (1 μg/mL to attach the GSC spheres). Cells were fixed with 4% paraformaldehyde for 30 min, permeabilized with 0.3% Triton X100 for 5 min, and blocked with 10% goat serum (Vector Laboratories). Cells were then incubated for 2 h at 37°C with monoclonal mouse anti-oligodendrocyte marker O4 (Olig4, 1:50; R&D Systems), neuron-specific beta III tubulin (TUBB3, 1:100; Abcam), polyclonal mouse anti-glial fibrillary acidic protein (GFAP, 1:50; Stemcell Technologies), rabbit SRY (sex determining region Y)-box 2 (Sox2, 1:50; Stemgent), and mouse cluster of differentiation (CD)44 (1:100, Cell Signaling). Complementary secondary antibody conjugated to a fluorophore (1:100, Life Technologies) was then added and incubated for 1 h. Cells were washed and nuclei were counterstained with 4′,6′-diamidino-2-phenylindole, mounted on a microscope slide, and analyzed by fluorescence microscopy.
Scratch Wound Healing Assay for Cell Migration
A monolayer of neurospheres (NS) and floating cell spheres (FC) cultured in the presence of 1 μg/mL Synthemax II-SC substrate (Corning) were scratched using a pipette tip to create a wound. Cells migrating from the leading edge were photographed at different time points
Importance of the study
We characterized a subpopulation of glioblastoma stem cells that escape adhesion/differentiation conditions and have enhanced cancer stem cell properties. These cells display stemlike properties with a molecular and phenotypic mesenchymal signature, including resistance to radiation and targeted therapies, a more aggressive tumor formation, and NFκB activation. Our results endorse cellular plasticity and intratumor molecular subtype heterogeneity in glioblastoma, which could have significant clinical implications. using phase-contrast microscopy. Distance was measured in 10× field using ImageJ (National Institutes of Health).
Flow Cytometry
For cell cycle analysis, cells were washed and fixed in 70% ethanol and incubated in phosphate buffered saline (PBS) containing 40 µg/mL propidium iodide and 200 µg/ mL RNase A (New England Biolabs). DNA content was analyzed by flow cytometry. CD44 expression was measured in 500 000 cells dissociated with 2 mM EDTA and incubated in 80 µL PBS/0.1% bovine serum albumin at 4°C for 30 min in the dark with mouse monoclonal anti-human CD44 antibody conjugated to fluorescein isothiocyanate (FITC, 1:10; Miltenyi Biotec) or respective mouse immunoglobulin G1 control in the presence of FcR blocking reagent (1:5). FITC was then analyzed with a LSR II Flow Cytometer System (BD Biosciences).
Mesenchymal Differentiation Assay
Differentiation of cells was performed using the StemPro Chondrogenesis Differentiation Kit (Life Technologies). Briefly, 2.5 × 10 5 NS or FC were cultured in osteocyte/chondrocyte basal medium supplemented with chondrogenesis supplement. After 21 days in culture, osteocytes/chondrocytes were stained with fast green and safranin O following the standard protocol.
Evaluation of NFκB Activity
NS were transduced with 2 lentiviral vectors expressing (i) secreted Gaussia luciferase (Gluc) under tandem repeats of the NFkB transcription responsive elements and (ii) secreted Vargula hilgendorfii luciferase (Vluc) under the control of the constitutively active SV40 promoter. These cells were differentiated in serum, and FC were collected from them and cultured as NS. Twentymicroliter aliquots of conditioned medium from each of NS and FC were assayed for Gluc activity (to measure NFkB activity) and Vluc activity (to normalize for cell number) using coelenterazine and vargulin substrate, respectively, as we previously described. 21, 22 The normalized Gluc/Vluc ratio was then calculated as a marker for NFkB activation.
In vivo Tumor Model
All animal studies were approved by the Massachusetts General Hospital Subcommittee on Research Animal Care following guidelines set forth by the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Female nude mice were anesthetized (100 mg/kg ketamine and 5 mg/kg xylazine) and stereotactically implanted with 5 × 10 4 GBM cells (as small spheres) expressing Fluc in 2 μL PBS via a 30-gauge Hamilton syringe into the left forebrain. Bioluminescence imaging was performed using the Xenogen IVIS 200 Imaging System (PerkinElmer) as we previously described. 23 
Statistical Analysis
GraphPad Prism v6.01 software was used for statistical analysis of all data. P < .05 was considered to be statistically significant. For analysis between multiple groups, a 1-way ANOVA was performed followed by Sidak's multiple comparison test to compare differences between 2 groups. An unpaired 2-tailed t-test was used for the comparison of 2 samples. Survival was analyzed using Kaplan-Meier curves and log-rank (Mantel-Cox) tests.
Results
A Subset of Patient-Derived GBM Stem Cells Escapes Differentiation Conditions and Forms Neurospheres in Culture
Patient-derived GBM stem cells (NS) undergo differentiation in culture by attaching to the culture dish in serum-containing medium or in the presence of other differentiating agents. Nonetheless, we observed that a small subset of these cells appears to escape adhesion/differentiation conditions and grow as FC ( Fig. 1A; Supplementary Fig. S1A ). We therefore raised the hypothesis that serum conditions yield in fact 2 different subpopulations. When these FC were separated from attached cells and cultured in serum, they showed to be fully viable ( Supplementary Fig. S1B ). When cultured in serum-free NBM, small 3-dimensional spheroids emerged (Fig. 1A) . These FC grew gradually over time and could be maintained and passaged as NS. On the other hand, when the adherent cell (AC) population were detached and resuspended in NBM, these cells formed small clusters which were more likely to be aggregates of cells, not morphologically spheres, and failed to generate secondary spheres (Fig. 1A) .
To investigate the ability of FC to form viable spheres, we used 8 well-characterized patient-derived GSC cultures (MGG6, MGG8, MGG23, MGG29, 84, 157, BT01, and BT07), which we have subtyped based on established gene expression profile (Supplementary Table S1 ). 9, 18, 19 One thousand single cells dissociated from NS as well as their corresponding AC and FC were cultured in NBM. After one week, we applied the extreme limiting dilution analysis (ELDA) algorithm 24 to calculate stem cell frequency and observed that FC had a significantly higher sphere formation frequency compared with NS (P < .01), while sphere formation by AC was ineffective (Fig. 1B) . In addition, we found that FC collected from U87MG and U251MG cell lines could grow and form secondary spheres in a similar frequency.
We noted that FC were especially abundant after AC being cultured in Dulbecco's modified Eagle's medium with fetal bovine serum (DMEM-FBS) for 4 to 5 days, and we sought to determine whether this phenomenon was due to the reduced pH in the medium, since previous studies have demonstrated that acidic conditions can favor GSC growth. 25 When a fluorogenic intracellular pH indicator was added into the culture medium, FC but not AC showed fluorescence indicating that the intracellular pH in FC is significantly lower (Fig. 1C) . Propidium iodide staining excluded that these cells could be dying or dead. In addition, secondary spheres formed from FC also showed substantially lower intracellular pH compared with their original NS (Fig.  1C ). When AC were dissociated and suspended in medium containing pHrodo-Green, these cells did not show any fluorescent signal (Fig. 1C) . We observed that DMEM-FBS (in the absence of cultured cells) had a slightly alkaline pH baseline (~7.9) after calibration in the standard CO 2 condition overnight (day 0) and gradually dropped to ~7.2 after 5 days and as low as ~6.5 after 8 days when conditioned by GBM cells (Fig. 1D, Supplementary Fig. S1A ). When 25 mM HEPES (4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid) was added to the culture medium, pH was maintained at above 7.5 for at least 6 days. Interestingly, the FC population collected from HEPES-stabilized medium could not survive in NBM, with only a few differentiated cells attached to the plate (Fig. 1D ). On the other hand, when 15 mM lactic acid, the biological metabolite in cellular respiration, was added to the medium, pH was reduced to ~6.5 and a large proportion of cells floated (Fig. 1D ). We also evaluated the conditioned medium collected at day 5, which had a stable low pH at around 6.5-6.8, and showed that this medium can induce FC formation ( Fig. 1D , Supplementary Fig. S1B ). Since hypoxic conditions have also been implicated in GBM progression, we investigated the effect of low oxygen levels on FC formation. Interestingly, combination of acidic conditions with low oxygen enhanced both FC development as well as primary and secondary sphere formation compared with acidic conditions alone ( Supplementary Fig. S2 ). These data suggest that acidic condition in combination with hypoxia facilitates the formation of FC and maintenance of sphereforming cells from differentiated GBM cells in culture.
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Floating Cell Spheres Retain Expression of Stem Cell Markers
To evaluate the stemlike properties of the FC population, we performed immunostaining for the stem cell representative marker Sox2 and a set of differentiation markers, including GFAP, Olig4, and TUBB3 in NS, FC, AC, and FC that were forced to differentiate in serum for >15 days (FC-AC). Similar to NS, FC exhibited positive immunoreactivity to Sox2, but no detectable immunoreactivity to GFAP, Olig4, or TUBB3. In contrast, both AC and FC-AC showed the opposite results ( Fig. 2A and Supplementary Fig. S3 ). We also analyzed mRNA from these cells by quantitative real-time (qRT)-PCR for a panel of biomarkers and observed that the expression of 9 different stem cell markers-SOX2; OCT-4; Nestin; BMI-1; KLF-4; Nanog; CD133; Olig2; and Sox 11-were significantly higher in FC and in the parental NS, compared with their corresponding differentiated adherent cells (FC-AC and AC). In turn, an increased expression of differentiation markers (GFAP and TUBB3) was observed in FC-AC and AC (Fig. 2B, Supplementary Fig. S4A ). These mRNA expression profiles were consistent with the protein expression patterns determined by western blotting. Elevated levels of GFAP, TUBB3 and NeuN (neuron nuclei protein) were observed in the differentiated cells, whereas NS and FC showed low-to-undetectable expression levels of these differentiation markers. Sox2, on the other hand, was enriched in FC and NS ( Fig. 2C and Supplementary Fig. S4B ).
Collectively these data suggest that FC retain the stemlike properties and can give rise to differentiated GBM cells.
Floating Cell Spheres Are Highly Tumorigenic In vivo
To evaluate the tumorigenic potential of FC compared with their parental NS, we sterotactically implanted 50 000 cells of NS, AC, FC, or FC-AC from MGG6 stably expressing the Fluc reporter into the brain of athymic mice (n = 7-10/group). Bioluminescence imaging showed that tumors formed by FC grew significantly faster compared with their corresponding NS tumors. At day 49, average Fluc activity in FC tumors was 204-fold higher compared with NS tumors (P < .001; Fig. 3A and B). Further, mice carrying FC-derived brain tumors had a significantly shorter survival compared with the NS group, with a median survival of 45 days for the FC group versus 55 days for the NS group (P = .0008; Fig. 3C ). The differentiated AC and FC-AC, however, were incapable of forming any tumors with mice surviving >100 days. We repeated the same experiment using GSCs 157 NS and their FC counterpart and observed similar results ( Fig. 3D-F ). Hematoxylin and eosin staining showed that FC formed much more aggressive tumors, which was translated into a significantly shorter mice survival compared with the NS group (median survivals were 37.5 and 21.5 days for NS and FC groups, respectively; P = .0015; Fig. 3F and Supplementary Fig. S5A ). In addition, FC isolated from U251MG glioma cell line (U251-FC) had a significantly higher tumor growth rate as compared with the parental U251MG cells (P = .012 at day 21; Supplementary Fig.  S5B-C) . Taken together, these data indicate that FCs induce an increased tumorigenic property in vivo.
Floating Cell Spheres Display Mesenchymal Properties
The ability of FC to survive and proliferate under extreme conditions (low pH and possibly low nutrients) along with their increased in vivo proliferation suggested a more aggressive tumor phenotype. A more detailed analysis of these 2 cell populations revealed a different molecular signature between NS and FC, with the latter exhibiting increased mesenchymal characteristics. The expression patterns of mesenchymal markers, including CD44, VIM, YKL-40, N-cad, MMP2, 11 and ALDH1A3 (recently characterized as a mesenchymal GSC marker) 7 were elevated in all FC samples compared with their parental NS (Fig. 4A , Supplementary Fig. S6A ). These results were confirmed in another set of FCs all showing higher CD44 expression compared with corresponding NS, irrespective of their original subtype (Supplementary Fig. S6B ). FC enhanced MES phenotype was also confirmed through upregulation of CD44 protein as well as increased levels of phosphorylated-STAT3 (pSTAT3) in 3 different GSCs (MGG23, MGG6, and MGG8; Fig. 4B ). C/EBPβ was also increased in FC from MGG23 and MGG8 but was undetected in their parental NS (Fig. 4B ). Fluorescence activated cell sorting (FACS) analysis confirmed that FC collected from 4 different GSC cultures (MGG6, MGG8, MGG23, and MGG29) have a significantly higher proportion of CD44 positive cells,
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despite different CD44 expression levels in NS ( Fig. 4C ; Supplementary Table S1 ). Finally, increased expression of CD44 was maintained in FC upon xenotransplantation in mice brain (Supplementary Fig. S5A ). These data collectively suggest that FC possess enhanced MES properties regardless of the originating GSC subtype.
We then asked whether higher mesenchymal markers in FC over NS are due to selection under culture condition or transformation of nonmesenchymal cells into a mesenchymal-like state. The cell surface marker CD44 is highly expressed in MES GBM and could be used as a surrogate marker for this subtype. 7 We collected the viable CD44 high and CD44 low subpopulations of MGG29 NS by FACS and labeled CD44 high cells with green fluorescent protein (GFP), and CD44 low cells with mCherry by transduction with corresponding lentivirus vectors (MGG29-CD44 high -GFP and MGG29-CD44 low -mCherry; Supplementary Fig. S7 ). These 2 subpopulations were then mixed together and cultured under serum conditions. When floating cells were collected from these cultures, we observed the presence of both GFP and mCherry expressing tumor cells. Flow cytometry analysis further showed that CD44 high cells can arise from both CD44 low cells and CD44 high cells altogether (Fig. 4D) . To confirm the mesenchymal-like transdifferentiation, we applied an in vitro model using the mesenchymal stem cell chondrogenic differentiation kit on both MGG8 NS and (Fig. 4E) . On the other Fig. S8 ). Finally, using the scratch wound healing assay, we observed that FC displayed a significantly greater migration potential compared with NS, consistent with a MES phenotype ( Fig. 4F and Supplementary Fig. S9 ).
Floating Cells Display Therapeutic Resistance
Since MES GSCs present an increased DNA damage repair capacity, 7, 9 we assessed the response of NS and FC to different known cancer therapeutics. The response to temozolomide (TMZ), the chemotherapeutic of choice for GBM, was first tested in 3 pairs of FC and NS cultures. NS from MGG6 and MGG8 were relatively sensitive to TMZ, with a halfmaximal inhibitory concentration (IC 50 ) of 33 μM and 5 μM, respectively, while MGG23 was more resistant, with an IC 50 of 350 μM. In contrast, all FC demonstrated increased resistance to TMZ (relative to their parental NS), with IC 50 of 127, 65, and >500 μM in MGG6, MGG8, and MGG23, respectively (Fig. 5A) . We further assessed the response of these cells to different doses of radiation therapy (3, 6, and 8 Gy). NS from MGG6 showed relatively higher radiosensitivity, while MGG23 had a moderate response and BT01 was relatively radioresistant. All 3 corresponding FC cultures showed a significantly higher resistance to radiation compared with parental NS (Fig. 5B) . Radiation is known to block the cells in the G2/M phase. Indeed, a 6 Gy dose induced significant G2/M cell cycle arrest in all NS compared with nonradiated cells. The percentage of cells in G2/M phase were 66.3%, 45.9%, and 27.3% in radiated MGG6, MGG8, and MGG29 NS, respectively. However, the percentage of G2/M phase cells was significantly decreased in corresponding FC, with only 34.7%, 26.5%, and 19.6% in MGG6, MGG8, and MGG29, respectively (Fig. 5C, Supplementary Fig. S10 ). Finally, we screened the "Target Selective Inhibitor Library" on MGG23 FC and NS and assessed cell viability. Thirty-seven compounds showed a decrease in cell viability (>25%). Among them, 29 compounds (78%) showed increased resistance in FC compared with NS (Fig. 5D ). We selected 6 of these hits for subsequent validation and confirmed increased therapeutic resistance in MGG8 FC compared with NS (Fig. 5E) . We further assessed the effect of 3 compounds (topotecan, NVP-BEP800, and Stattic) on sphere formation using ELDA and observed that stem cell frequency in FC was significantly higher compared with NS posttreatment (Fig. 5F ). These results demonstrate the increased self-renewal and treatment resistance of the FC population compared with their parental NS.
NFκB Regulates Floating Cell Spheres Formation
Intrinsic activation of various transcription factors has been shown to promote a MES switch in cancer cells, including gliomas. 7, 13, 14 Particularly, the transcription factor NFκB, a master regulator of the cellular stress response, 26 promotes MES differentiation in GBM, in response to radiation. 7 Using an NFκB bioluminescent reporter system based on the secreted Gaussia luciferase (Gluc), 21 we showed that FC had a significantly higher level of NFκB activation compared with corresponding NS in 3 different GBM cultures (MGG6, MGG8, MGG23; Fig. 6A ). These results were confirmed by western blotting and qRT-PCR showing increased phosphorylation of p65 (ser536) and markedly higher mRNA expression of 5 NFκB target genes (TNFAIP3 [tumor necrosis factor alpha induced protein 3], CXCL2 [C-X-C motif chemokine ligand 2], ICAM1 [intercellular adhesion molecule 1, aka CD54], IL1β (interleukin 1beta), and NQO1 [NAD(P)H quinone dehydrogenase 1]) in FC compared with parental NS (Fig.  6B-C) . To determine whether NFκB activation is required for the generation of FC, we stably expressed GFP, along with a mutant super-repressor form of inhibitor of kappa B (IκB)α (GFP-mutant IκBα) 26 in NS. This mutant IκBα is resistant to phosphorylation and degradation, thereby inhibiting NFκB activity in the transduced GFP(+) cells. 27 Proneural GSC cultures 84 and 157 were engineered to achieve approximately 30% transduction efficiency, based on GFP expression (assessed by flow cytometry), thereby generating a mixed population of GSCs expressing both wild type IκBα/ GFP(−) and mut IκBα/GFP(+). These cells were subsequently attached in serum-containing medium and allowed to form FC. Remarkably, none of the FC generated showed any GFP expression (and therefore IκBα), suggesting that NFκB activation is needed to generate FC ( Supplementary Fig. S11 ).
Discussion
Substantial evidence suggests that a subset of solid tumors contain cancer stem cells which play an important role in tumor initiation, progression, metastasis, and therapeutic resistance. 1,2 GBM stem cells in particular may possess several unique characteristics that make them resistant to conventional chemo-and radiotherapy, such as high expression of drug transporters, relative cell-cycle quiescence, high function of DNA repair machinery, and resistance to apoptosis. 5, 28 GSCs reside in a tumor niche where both the stemness status and angiogenesis are conditioned by the microenvironment, such as hypoxia, due to limited oxygen availability, and low pH caused by accumulation of acidosis products of the glycolytic metabolism. When patientderived GSCs are cultured in serum-containing medium to induce differentiated and nontumorigenic cells, we show that a subpopulation of these tumor cells escapes adhesion/differentiation and maintains the ability to self-renew by forming secondary spheres with enhanced GSC MES properties. These results endorse intratumor molecular subtype heterogeneity in GBM, recently described using single cell RNA sequencing. 10 Whether these cells are preexistent and selected from the initial "undifferentiated" NS population and subsequently enriched in FC or are dedifferentiated from mature GBM cells is debatable. The cell surface marker CD44 is highly expressed in MES GBM and could be used as a surrogate marker for this subtype. 7 We show that both CD44 high and CD44 low GSCs can generate FC harboring high levels of CD44 with enhanced MES phenotype (irrespective of original subtype), suggesting the presence of a genetic switch as one mechanism leading to an enriched tumorigenic stem cell population in FC. Further, gliomas and GSCs tend to shift toward a more MES phenotype upon intrinsic activation of various transcription factors such as STAT3, C/EBPβ, and NFkB, 7,9,13 all of which were increased/ activated predominantly in FC. These data suggest that the cell culture environment, including acidic and hypoxic conditions, results in intrinsic activation of transcription factors that promote a pro-MES switch. Previous studies have suggested that derivation of spheres from cancer cell lines or primary culture cells and extrinsic conditions such as therapeutic and/or physiological stress often lead to a phenotypic switch. This is reminiscent of an epithelial-to-mesenchymal transition (EMT) observed in a variety of tumor types and generally leads to increased invasiveness and acquired resistance to various environmental insults. 29 GSCs isolated from MES GBM tumors tend to lose their MES properties and present a PN signature once grown in NS-forming culture conditions, even at early passages in vitro. 7 This loss of MES identity has been attributed to the change of tumor microenvironment that is likely to promote and maintain MES properties. Acidic extracellular pH and low oxygen tension are major pathophysiological features in solid tumor tissues, primarily due to lactate secretion from anaerobic glycolysis, and have been suggested to promote local invasion. 30 Neutralizing acidic pH with sodium bicarbonate has been shown to increase the therapeutic response to chemotherapy and to inhibit metastasis. 31 In the case of malignant gliomas, acidic stress (pH 6.6) is partly responsible for promoting a GSC phenotype and increasing vascular endothelial growth factor expression, which typically correlates with tumor progression. 25 Electrode measurements of pH in human brain tumors demonstrated a pH as low as 5.9 with a mean around 6.8, with the normal brain tissue having a pH of ~7.1. 25, 32 In contrast, cell culture media, including NBM, which are widely applied to grow GSCs, have a slightly alkaline pH at baseline and are designed to maintain neutral pH during cellular growth. Our results suggest that low pH through secretion of lactic acid in the conditioned medium is a major contributor in maintaining GBM intratumor molecular subtype heterogeneity and MES switch in culture and that low oxygen potentially facilitates these phenomena. Considering our findings and other studies linking hypoxia to GSCs, cell culture under reduced oxygen tension and pH might be more appropriate to enable in vitro maintenance of the physiologically relevant inherent cellular heterogeneity found in GBM. 33 Recently, invasive circulating tumor cells with MES properties have been identified for the first time in peripheral blood samples of glioma patients. 34 This finding reinforces the idea that an EMT-like process does occur in GBM patients as well. It remains to be determined whether the similarities between the FC from primary GBM cultures and circulating tumor cells from GBM patients extend beyond the phenotypic resemblance (loss of adhesion) and gain of MES properties. More studies will also help determine whether MES transition in FC is complete or reversible following longterm culture in standard stem cell culture conditions. GSCs 
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with MES properties present a more aggressive phenotype both in culture and in vivo, along with a pronounced radioresistance. 7, 9 Further, plasticity between PN to a MES phenotype is observed upon GBM recurrence, or in response to radiation therapy. 7, 9, 12 Thus, in vitro modeling of MES transition could be highly beneficial in understanding the main drivers of this switch that leads to treatment resistance or tumor recurrence. 35, 36 While further characterization of the FC population is needed in order to assess their clinical relevance, the aggressive phenotype and enhanced therapeutic resistance of these cells make them a valuable model to maintain/study intratumor heterogeneity and GSC plasticity and to test novel therapeutics aiming at eradicating GBM in general and GSCs in particular.
Conclusions
Patient-derived GBM stemlike cells undergo differentiation when cultured in serum-containing medium; however, a small subpopulation of these cells escapes this adhesion/differentiation and grow as floating cells. These cells revealed enhanced GSC properties with MES genotype/ phenotype along with increased migration/invasion, resistance to therapy, and tumor formation in vivo. Our findings support GBM inherent intratumor molecular subtype heterogeneity as well as GSC plasticity, which could have significant clinical implications.
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